Compare CXDO & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CXDO | FOCL |
|---|---|---|
| Founded | 1995 | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 203.7M |
| IPO Year | 1999 | 1998 |
| Metric | CXDO | FOCL |
|---|---|---|
| Price | $6.26 | $4.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | ★ 334.4K | 194.6K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 166.67 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | $68,167,000.00 | ★ $70,527,000.00 |
| Revenue This Year | $45.26 | N/A |
| Revenue Next Year | $13.31 | N/A |
| P/E Ratio | $128.40 | ★ N/A |
| Revenue Growth | ★ 12.05 | 1.63 |
| 52 Week Low | $5.55 | $4.01 |
| 52 Week High | $11.23 | $6.40 |
| Indicator | CXDO | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 35.06 |
| Support Level | $6.18 | $4.01 |
| Resistance Level | $6.76 | $5.64 |
| Average True Range (ATR) | 0.21 | 0.28 |
| MACD | 0.03 | -0.06 |
| Stochastic Oscillator | 43.33 | 15.59 |
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.